News
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
The FDA has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a pre-exposure prophylaxis (PrEP) against ...
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results